How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Purification by Chromatography in Downstream Processing Market
- By Chromatography Technique: Affinity Chromatography, Ion Exchange Chromatography, Size Exclusion Chromatography, Hydrophobic Interaction Chromatography, Mixed-Mode Chromatography
- By Application: Biopharmaceuticals Purification, Vaccine Purification, Enzyme Purification, Antibody Purification, Gene Therapy Product Purification
- By End-User: Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutes, Biotechnology Companies, Pharmaceutical Companies
- By Product Type: Chromatography Resins and Media, Chromatography Columns, Chromatography Systems and Instruments, Chromatography Consumables and Accessories
- By Process Stage: Capture Chromatography, Intermediate Purification, Polishing Chromatography
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Affinity Chromatography leads By Chromatography Technique at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Purification by Chromatography in Downstream Processing Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Chromatography Technique 5
Application 5
End-User 5
Product Type 4
Process Stage 3
Companies profiled
Cytiva (formerly GE Healthcare Life Sciences)
Sartorius AG
Thermo Fisher Scientific
Merck KGaA (MilliporeSigma)
Bio-Rad Laboratories
Tosoh Corporation
Agilent Technologies
Repligen Corporation
Pall Corporation (a part of Danaher)
Sepax Technologies
Phenomenex (acquired by Danaher)
ChromaCon AG
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cytiva (formerly GE Healthcare Life Sciences)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Tosoh Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Agilent Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Repligen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Pall Corporation (a part of Danaher)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Sepax Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Phenomenex (acquired by Danaher)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →ChromaCon AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →BIA Separations
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →JNC Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,459M by 2033 · 10.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Affinity Chromatography45.6
- Ion Exchange Chromatography17.4
- Size Exclusion Chromatography17.5
- Hydrophobic Interaction Chromatography10.3
- Mixed-Mode Chromatography9.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,601M → $3,191M · 9.0%
Europe$1,116M → $2,522M · 10.7%
Asia Pacific$1,019M → $2,353M · 11.0%
Latin America$630.8M → $1,283M · 9.3%
Middle East and Africa$485.2M → $1,048M · 10.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.032026
10.042027
10.042028
10.062029
10.072030
10.092031
10.112032
10.112033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cytiva (formerly GE Healthcare Life Sciences)19.8
- Sartorius AG19.9
- Thermo Fisher Scientific4.7
- Merck KGaA (MilliporeSigma)11.4
- Bio-Rad Laboratories7.3
- Tosoh Corporation8.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Chromatography Technique16.9%
Application25.2%
End-User24.6%
Product Type14.5%
Process Stage18.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe24.3
- Asia Pacific22.6
- Latin America12.3
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cytiva (formerly GE Healthcare Life Sciences) | 73 | 95 | 73 | 79 | 92 | 84 | 83 |
| Sartorius AG | 84 | 82 | 72 | 68 | 83 | 92 | 80 |
| Thermo Fisher Scientific | 75 | 62 | 83 | 83 | 68 | 73 | 74 |
| Merck KGaA (MilliporeSigma) | 78 | 69 | 63 | 62 | 58 | 62 | 65 |
| Bio-Rad Laboratories | 63 | 61 | 58 | 62 | 62 | 71 | 63 |
| Tosoh Corporation | 71 | 66 | 63 | 69 | 61 | 56 | 64 |
| Agilent Technologies | 54 | 49 | 59 | 41 | 43 | 62 | 51 |
| Repligen Corporation | 45 | 54 | 50 | 49 | 59 | 43 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cytiva (formerly GE Healthcare Life Sciences)
- Sartorius AG
- Thermo Fisher Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cytiva (formerly GE Healthcare Life Sciences) | ◐ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Sartorius AG | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Thermo Fisher Scientific | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Merck KGaA (MilliporeSigma) | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| Bio-Rad Laboratories | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Tosoh Corporation | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Agilent Technologies | − | − | ◐ | − | − | ◐ |
| Repligen Corporation | − | ◐ | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cytiva (formerly GE Healthcare Life Sciences)83
2Sartorius AG80
3Thermo Fisher Scientific74
4Merck KGaA (MilliporeSigma)65
5Tosoh Corporation64
6Bio-Rad Laboratories63
7Agilent Technologies51
8Repligen Corporation50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Cytiva (formerly GE Healthcare Life Sciences)Sartorius AG
Challenger1
Strong scale, closing on the leaders.
Thermo Fisher Scientific
Contender3
Focused players with pockets of strength.
Merck KGaA (MilliporeSigma)Bio-Rad LaboratoriesTosoh Corporation
Niche2
Specialists in a single segment or region.
Agilent TechnologiesRepligen Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Chromatography Technique in North America, then scale across Purification by Chromatography in Downstream Processing Market — a $423M beachhead inside a $6.12B market.
Beachhead (SOM)$423Mobtainable near-term
Serviceable (SAM)$2.54Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Affinity Chromatography
Best fit — highest urgency & budget in Chromatography Technique.
Economic buyer77 fit
Ion Exchange Chromatography
Strong fit — clear ROI and a fast path to value.
End user66 fit
Size Exclusion Chromatography
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Chromatography Technique in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Chromatography Technique leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Purification by Chromatography in Downstream Processing Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified20%
Evaluation14%
Closed-won6%
$10.2KCAC
$36KLTV
3.6:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Purification by Chromatography in Downstream Processing Market is a high-growth opportunity — $11.6B by 2033, compounding at 11.6%.
TAM · 2025$4.82Btoday
TAM · 2033$11.6Bforecast
CAGR11.6%2027–2033
Cumulative$70.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.6BTotal addressable market
SAM$4.85BServiceable available market
SOM$792MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.6% CAGR
Demand compounds through 2033, outpacing GDP across Chromatography Technique.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Chromatography Technique moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.6BLarge & growingTAM by 2033 at 11.6% CAGR
$4.85BServiceable nowreachable with today’s model
$792MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$9.05BBear7.5% CAGR
$11.6BBase11.6% CAGR
$14.9BBull15.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Purification by Chromatography in Downstream Processing Market — a $2.89B market by 2033. Plan: grow share from 9.6% to 15.9%.
Market size · 2033$2.89Btotal addressable
Market CAGR5.6%2027–2033
Target share15.9%from 9.6% today
Revenue ambition$460Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.6% | 15.9% | On track |
| Revenue | $265M | $460M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.2% | 44.0% | On track |
| Customer retention | 91.9% | 96.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Chromatography Technique
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Chromatography Technique share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $62M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Chromatography Technique leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Purification by Chromatography in Downstream Processing Market conversation — a $12.8B market you can size, segment and defend in minutes.
Market size · 2033$12.8Btotal opportunity
Growth11.7%CAGR to 2033
Addressable buyers1,008+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Chromatography Technique
Goal Grow share in Chromatography Technique
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 3 mopayback period
$54K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Cytiva (formerly GE Healthcare Life Sciences)Sartorius AGThermo Fisher ScientificMerck KGaA (MilliporeSigma)Bio-Rad LaboratoriesTosoh CorporationAgilent TechnologiesRepligen Corporation+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Purification by Chromatography in Downstream Processing Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Purification by Chromatography in Downstream Processing Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Pure Titanium Dental Implants Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportPure Steam Sampler Market
Market size, share, segmentation and regional forecast.
$367M market · 2025 base year
View reportPure NMN Powder Market
Market size, share, segmentation and regional forecast.
$518M market · 2025 base year
View reportPure Natural Collagen Suture Market
Market size, share, segmentation and regional forecast.
$742M market · 2025 base year
View reportPure Cortical Bone Granules Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportPure Biotin Market
Market size, share, segmentation and regional forecast.
$426M market · 2025 base year
View reportPupil Distance Meter Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportPupil Distance Measuring Instrument Market
Market size, share, segmentation and regional forecast.
$315M market · 2025 base year
View reportPupil Dilator Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportPuncture Surgery Navigation System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportPuncture Surgery Navigation And Positioning System Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportPuncture Dilators Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.